Literature DB >> 17463151

Noninvasive measurement of transit time in short bowel syndrome.

Charlene Compher1, Stephen Rubesin, Bruce Kinosian, Julie Madaras, David Metz.   

Abstract

BACKGROUND: Patients with short bowel syndrome (SBS) have limited absorption of nutrients, in part because of the rapidity with which chyme passes through the bowel. We sought to evaluate noninvasive measurements of intestinal transit time to aid in research questions where transit is measured repeatedly.
METHODS: Three methods were compared in 8 patients with SBS: the time for blue food color to appear in ostomy effluent or stool, lactulose breath hydrogen testing, and the first radiopaque ring from a capsule in timed stool samples.
RESULTS: Median blue dye fasted transit was 96.3 minutes, with breakfast was 117.3 minutes, and with lactulose was 72 minutes. By breath hydrogen testing, transit time was 52.5 minutes but detectible in only 5 of 13 tests. Transit time by radiopaque marker was 967 minutes, but no markers passed in 7 of 14 tests.
CONCLUSIONS: Visualization of blue food color in ostomy effluent is a simple, inexpensive approach that can be applied to fasted subjects or after specific meals. Breath hydrogen testing should only be applied in the rare patient with SBS who has an intact ileocecal valve. Radiopaque markers are less useful, most likely because they become trapped due to anatomic changes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17463151     DOI: 10.1177/0148607107031003240

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  4 in total

1.  Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome.

Authors:  Susan Lapthorne; Prue M Pereira-Fantini; Fiona Fouhy; Guineva Wilson; Sarah L Thomas; Nicole L Dellios; Michelle Scurr; Orla O'Sullivan; R Paul Ross; Catherine Stanton; Gerald F Fitzgerald; Paul D Cotter; Julie E Bines
Journal:  Gut Microbes       Date:  2013-04-02

2.  Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.

Authors:  Sarah Alrubia; Jialin Mao; Yuan Chen; Jill Barber; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2022-09-03       Impact factor: 5.577

Review 3.  The complexities of the diet-microbiome relationship: advances and perspectives.

Authors:  Emily R Leeming; Panayiotis Louca; Rachel Gibson; Cristina Menni; Tim D Spector; Caroline I Le Roy
Journal:  Genome Med       Date:  2021-01-20       Impact factor: 11.117

4.  Blue poo: impact of gut transit time on the gut microbiome using a novel marker.

Authors:  Francesco Asnicar; Emily R Leeming; Eirini Dimidi; Mohsen Mazidi; Paul W Franks; Haya Al Khatib; Ana M Valdes; Richard Davies; Elco Bakker; Lucy Francis; Andrew Chan; Rachel Gibson; George Hadjigeorgiou; Jonathan Wolf; Timothy D Spector; Nicola Segata; Sarah E Berry
Journal:  Gut       Date:  2021-03-15       Impact factor: 31.793

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.